Aqemia
PrivateLast Round
Grant
Apr 1, 2025
Total Funding Raised
$70.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aqemia is a pharmatech company that utilizes a platform combining generative AI with quantum-inspired physics to accelerate the discovery of small-molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqemia Comparables
Compare Aqemia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qubit Pharmaceuticals | 90% | |
| Iktos | 88% | |
| Evariste | 86% | |
Aqemia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2025 | ||||
| VC Round | Dec 10, 2024 | ||||
| Series A Extension | Jan 30, 2024 | ||||
| Series A | Oct 19, 2022 | ||||
| Pre Seed | Oct 17, 2019 |
Key People
Founding team and executive leadership
Aqemia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Wendel Growth | Series A Extension |
| Elaia Partners | Series A, VC Round, Series A Extension, Pre Seed |
| Wendel Group | VC Round |
| Bpifrance | VC Round, Series A Extension, Pre Seed, Series A |
| Eurazeo | VC Round, Series A Extension, Series A |
| Cathay Innovation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
Aqemia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aqemia's valuation, stock price, and market status.